GIP Activators
GIP activators encompass a diverse range of chemical entities, each uniquely positioned to modulate the activity of Gastric Inhibitory Polypeptide through various indirect biochemical pathways. These compounds, although not directly interacting with GIP, can influence its secretion or activity by modulating the cellular environment or signaling cascades that indirectly impact GIP dynamics. The class of GIP activators includes compounds that modulate cAMP levels, such as Forskolin and Dibutyryl-cAMP. By elevating cAMP, these compounds activate protein kinase A (PKA), which can modulate various cellular processes, potentially influencing GIP secretion in enteroendocrine cells. This mode of action highlights the significance of second messengers in cellular signaling and their indirect effects on peptide hormone secretion.
Another key group within this class involves compounds that alter intracellular calcium levels, such as A23187 (Calcimycin) and Phorbol 12-myristate 13-acetate (PMA), a PKC activator. Calcium and PKC are crucial in numerous signaling pathways, and their modulation can indirectly impact GIP secretion, underscoring the intricate interplay of intracellular signaling molecules in hormone regulation. Furthermore, compounds like EGF and Glucagon, though primarily associated with other physiological functions, are included in this class due to their potential to indirectly influence GIP activity through their respective signaling pathways. EGF, for instance, activates the MAPK/ERK pathway, affecting cellular growth signals, which could have downstream effects on GIP secretion.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, found in the plant Coleus forskohlii, activates adenylyl cyclase, increasing cAMP levels in cells. Elevated cAMP can enhance protein kinase A (PKA) activity, which may indirectly influence GIP secretion by modulating cellular processes in enteroendocrine cells. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). PKC activation can lead to changes in cellular signaling pathways that may influence GIP secretion, particularly through modulation of intracellular calcium levels. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that can permeate cell membranes, effectively raising intracellular cAMP levels. This elevation can activate PKA, potentially affecting GIP secretion indirectly by altering intracellular signaling dynamics. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of Vitamin B3, can influence cellular metabolism and is involved in redox reactions. It may affect GIP secretion indirectly through its role in metabolic pathways and cellular energy status. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium levels, potentially affecting GIP secretion through calcium-dependent signaling pathways. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through its receptors, can influence various intracellular signaling pathways, including those involving cAMP and calcium, which may indirectly affect GIP secretion. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences intracellular signaling, particularly in the phosphoinositide pathway, which could indirectly affect GIP secretion. | ||||||